Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repros Therapeutics Inc (NASDAQ:RPRX)

1.80
Delayed Data
As of Jul 28
 +0.10 / +5.88%
Today’s Change
0.80
Today|||52-Week Range
8.96
+48.76%
Year-to-Date
No recent news for Repros Therapeutics Inc.

Today’s Trading

Previous close1.70
Today’s open1.71
Day’s range1.71 - 1.85
Volume224,870
Average volume (3 months)2,005,520
Market cap$41.3M
Dividend yield--
Data as of 07/28/2016

Growth & Valuation

Earnings growth (last year)+13.67%
Earnings growth (this year)+14.44%
Earnings growth (next 5 years)+27.95%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.23

Competitors

 Today’s
change
Today’s
% change
IPCIIntellipharmaceutics...0.000.00%
PRANPrana Biotechnology ...+0.03+0.73%
VICLVical Inc0.000.00%
BLRXBioLine RX Ltd-0.03-3.29%
Data as of 3:34pm ET, 07/28/2016

Financials

Next reporting dateAugust 8, 2016
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$0.00
Annual profit (last year)-$29.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Joseph S. Podolski
Secretary, Chief Financial &
Accounting Officer
Katherine A. Anderson
Corporate headquarters
Woodlands, Texas

Forecasts

Partner Offers

Search for Jobs